Statistical aspects of quantitative image analysis of β-amyloid in the APPV717F transgenic mouse model of Alzheimer's disease

Journal of Neuroscience Methods

Volumn 108, Issue 2, 2001, Pages 145-152

  Fishman, Cindy E ^a   Cummins, David J ^b   Bales, Kelly R ^b   DeLong, Cynthia A ^b   Esterman, Michail A ^b   Hanson, Jeffery C ^b   White, Sandy L ^b   Paul, Steven M ^b   Jordan, William H ^b  

^a PURDUE UNIVERSITY   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

amyloid, Histopathology; Alzheimer's disease; Animal model; Image analysis; Mouse; Power analysis; Quantitative

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; IMAGE ANALYSIS; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SAMPLING; TISSUE SECTION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CELL COUNT; DATA INTERPRETATION, STATISTICAL; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; REPRODUCIBILITY OF RESULTS; SENILE PLAQUES; STATISTICAL DISTRIBUTIONS; THIAZOLES;

EID: 0035974231     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(01)00381-8     Document Type: Article

References (29)

1. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease
2. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition
3. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
4. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins
5. Neuron loss in APP transgenic mice
6. Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V717I transgenic mice by a different mechanism than mutant presenilin1
7. Prospects for noninvasive imaging of brain amyloid beta in Alzheimer's disease
8. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein
9. High-throughput quantitative histological analysis of Alzheimer's disease pathology using a confocal digital microscanner
10. Amyloid, the presenilins and Alzheimer's disease
11. Alzheimer's disease: the amyloid cascade hypothesis
12. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
13. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model
14. Correlative memory deficits, abeta elevation, and amyloid plaques in transgenic mice
15. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1
16. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse
17. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease
18. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease
19. Comparison of pathological diagnostic criteria for Alzheimer disease
20. Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging
21. Brain trauma in aged transgenic mice induces regression of established abeta deposits
22. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model
23. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
24. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease
25. Alzheimer's disease: a central role for amyloid
26. In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease
27. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
28. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease